Sporadic Lymphangioleiomyomatosis Disease: A Case Report

Pulmonary Lymphangioleiomyomatosis (LAM) is a rare disease of the lung and lymphatic system that primarily affects women of childbearing age. LAM is a progressive disease with a terrible prognosis, which worsens over time and is extremely difficult to treat. In this study, we discuss the case of a 31-year-old woman with LAM who was initially misdiagnosed with leiomyoma and the way that led to a true diagnosis and effective treatment. Following a precise diagnosis based on comprehensive clinical data and particular immunohistochemical tests, sirolimus treatment was initiated, and the patient entirely responded to the treatment. This case report demonstrated that LAM is an uncommon condition that is challenging to diagnose, which causes its treatment to be delayed

The health endpoint due to exposure organophosphorus toxicant

Background/objectives: Organophosphorus compounds are extremely predominant in terms of agricultural and commercial activities. The aim of this review study was to assess the health endpoint due to organophosphorus toxicant. Methods: This study was conducted based on databases including Web of Science, Science Direct, PubMed, Springer, and Google Scholar. Results: The result of this study showed that the severity of the symptoms, which include acute cholinergic syndrome and intermediate syndrome, depends on the dose received, the exposure duration, and the patient's health status. Conclusion: Long-term or short-term exposure to organophosphorus toxins will cause symptoms of poisoning and disruption of the nervous system sites